Athira Pharma, Inc.
ATHA
$0.295
-$0.008-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.28% | 45.01% | 12.83% | 9.25% | 5.33% |
| Total Depreciation and Amortization | 0.41% | -0.82% | -0.41% | -0.82% | 2.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.91% | 13.19% | 36.54% | 12.04% | -1.00% |
| Change in Net Operating Assets | -238.61% | -977.99% | -61.54% | -48.46% | -96.58% |
| Cash from Operations | 43.17% | 1.06% | 4.01% | 8.04% | 1.49% |
| Capital Expenditure | -- | -- | 100.00% | 15.15% | 97.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -156.35% | -144.00% | -12.94% | -18.23% | -63.52% |
| Cash from Investing | -156.37% | -144.00% | -12.81% | -18.24% | -63.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -77.63% | -- | -38.84% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -77.63% | -- | -38.84% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.50% | -45.78% | -50.94% | -48.14% | -235.39% |